Skip to content

GBGAA-E1 -Informed Consent/Refusal for Hepatitis B Virus Vaccination

Policies · Adopted policies and procedures · 2 pages · 739 words · all RSU 5 documents · the district's file →

Text copied out by software, not the document itself. Layout, tables and figures may not survive. The district's copy is authoritative; check it before relying on this text.

NEPN/NSBA Code: GBGAA-E1

INFORMED CONSENT/REFUSAL FOR HEPATITIS B VIRUS VACCINATION

I, the undersigned employee, have read the back side of this form regarding information about Hepatitis B and the Hepatitis vaccine. I understand that due to my occupational exposure to blood or other potentially infectious materials, I may be at risk of acquiring Hepatitis B virus (HBV) infection in the workplace. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself.

I further understand that risks involved in making this decision and I agree that the school system, its agents and employees, who are required by law or regulation to make the Hepatitis B Vaccine available to me, are not legally responsible or liable for the side effects that may occur as a result of my accepting/not accepting the Hepatitis B Vaccine.

_______ I have opted to decline the Hepatitis B Vaccine at this time, I have already had the Hepatitis B Vaccine.

_______ I agree to accept the Hepatitis B Vaccine, given in three (3) doses over the next 6 months. (If you are pregnant or breastfeeding, it is advisable that you consult with a doctor before taking the Hepatitis B Vaccine series.)

________ I have opted to decline the Hepatitis B Vaccine at this time. I understand that by declining this vaccine, I continue to be at risk of acquiring Hepatitis B, a serious disease. If in the future I continue to have occupational exposure to blood or other potentially infectious materials and I want to be vaccinated with Hepatitis B Vaccine, I can receive the vaccination series at no charge to me.

Print Name: _______________________________ Title: ____________________

Signature: ________________________________ Date: ____________________

School/Location: _____________________________________________________

Witness: _________________________________ Date: _____________________

Adopted:​   June 9, 2010
Reviewed:​ February 29, 2012
Moved to Administrative Procedure: October 24, 2018
Revised:​   May 7, 2025

RSU No. 5 School Department

Page 1 of 2

NEPN/NSBA Code: GBGAA-E1

HEPATITIS B VIRUS VACCINE INFORMATION

For your information – Please Read Carefully

The disease – Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) which causes death in 1% to 2% of patients infected. Most people with Hepatitis B recover completely but approximately 5% to 10% become chronic carriers of the virus. Most of these people have no symptoms but can continue to transmit the disease to others. Some may develop chronic hepatitis or cirrhosis. Carriers face other problems, too. They run a high risk of developing primary liver cancer and pregnant carriers transmit the HBV through the placenta with some 90% of infected infants becoming carriers.

Simple, Effective Solution – Fortunately, now, there is a simple way to prevent HBV infection. The Centers for Disease Control (CDC) recommends vaccination for anyone frequently exposed to blood or other body fluids in the work place. If you fall into this category, the CDC says that 15% to 25% of these above specified health care workers will contract Hepatitis B during their careers. Your individual risk is directly related to how often you are exposed to blood and other body fluids.

The Vaccine – The Hepatitis B Vaccine currently used is a noninfectious vaccine made from bread yeast (Saccharomyces cerevisiae). When injected into the deltoid muscle, the hepatitis vaccine has induced protection levels of antibody in more than 90% of the healthy individuals who received the recommended three doses of the vaccine. Persons with immune-system abnormalities, such as dialysis patients, have less response to the vaccine; but over half of those receiving it do develop antibodies. Full immunization requires three doses of vaccine over a six month period although some persons may not develop immunity even after three months. There is not evidence that the vaccine has ever caused Hepatitis B. However, persons who have been infected with Hepatitis B virus prior to receiving the vaccine may go on to develop clinical hepatitis in spite of immunization. The duration of immunity is unknown at this time.

Possible Adverse Side Effects – the incidence of side effects is very low. No serious side effects have been reported with the vaccine. A few persons have experienced:

●​ Soreness, swelling, warmth, itching, redness, bruising and nodule formation at the injection site.

●​ Fever + 100 degrees F and malaise ●​ Tiredness/weakness ●​ Headache ●​ Nausea and/or diarrhea

●​ Sore throat and/or upper respiratory infection

●​ Dizziness ●​ Muscle aches ●​ Joint pain

RSU No. 5 School Department

Page 2 of 2

Source: , linked from www.rsu5.org/board-of-directors-and-policies/adopted-policies-and-procedures. Text copied out by software (pdftotext); no wording corrected.